Clinical, Laboratory, and Imaging Features of 148 Patients with COVID-19 in Bushehr: A Report from the South of Iran

Introduction

In December 2019, a series of fatal pneumonia cases of unknown etiology was identified in Wuhan City, Hubei Province of China. In January 2020, the Chinese authorities reported that the causative agent was a previously unknown coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In February 2020, the World Health Organization (WHO) officially named the disease caused by the SARS-CoV-2 as coronavirus disease-2019 (COVID-19) [1]. Up to July 4, 2020, COVID-19 had been recognized in 216 countries and territories, with a total number of reported laboratory-confirmed cases being 10 922 324 and deaths being 523 011 [2]. Iran is the most affected country by COVID-19 in the Eastern Mediterranean region, and the first cases of the disease was reported on February 20, 2020. The Iranian Ministry of Health (MoH) reported that as of 4 July 2020, there had been 237 878 confirmed cases of the infection and 11 408 deaths in Iran due to COVID-19 [3].

Based on the genome sequence data, it has been revealed that SARS-CoV-2 is a member of the genus Betacoronavirus within the family Coronaviridae [4]. It is an enveloped virus with a single strand, positive-sense RNA genome. Following transmission by inhalation of respiratory droplets, contact with contaminated surfaces, or fecal-oral route, and other means, viral replication takes place in cells of the respiratory and gastrointestinal tracts. The average incubation period of the disease is reported to be 2-14 days, however, there is evidence that it can last as long as 19-27 days [5].

The clinical manifestations of COVID-19 can range from asymptomatic mild disease to severe respiratory failure requiring hospital admission and mechanical ventilation [6]. The main clinical symptoms in COVID-19 patients are fever, cough, fatigue, and sore throat [7]. Although, many studies have been published regarding the clinical characteristics of COVID-19 patients from different countries, there are only few published from Iran. Therefore, this study aimed to investigate clinical, laboratory, and imaging findings of patients infected with COVID-19 in Bushehr, a southern province of Iran.

Patients & methods

Results

Laboratory and radiographic findings

Considering the blood leukocytes, the count of WBCs had no significant difference between two groups (6.60±3.31 vs. 6.41±2.12, P= 0.39). However, lymphocyte counts were lower in the inpatient group in comparison to the outpatient group (1.36±0.76 vs. 2.04±0.90, P< 0.0001). With respect to the inflammatory markers, ESR was significantly higher in the inpatients in comparison to the outpatients (44.99±26.48 vs. 17.95±17.97; P< 0.0001). Additionally, CRP level was significantly higher among the inpatients than the outpatients (49.02±35.72 vs. 15.49±24.55; P< 0.0001; Table 2). Both BUN and creatinine levels were higher in the inpatients in comparison to the outpatients, but the differences were not statistically significant (P= 0.84 and P= 0.48, respectively). Moreover, CPK levels did not have significant change between two groups (P= 0.41). However, LDH level was higher among the inpatients than the outpatients (559.57±380.54 vs. 358.97±119.83, P< 0.0001). Among the liver enzymes, AST level was significantly higher in the inpatient group compared to the outpatient group (38.84±38.77 vs. 26.16±13.66; P< 0.001). However, no statistically significant difference was detected between two groups (36.77±45.99 vs. 30.16±22.38, P= 0.39; Table 2).

View this table:

• View inline
• View popup

Table 2.

Baseline data and paraclinical findings of the study participants.

Regarding age group, we observed a significant increase in the levels of ESR among the elderly patients (56.65±27.25 mm/h) compared to the non-elderly patients (29.52±23.98 mm/h) (P<0.0001). Also, the levels of CRP were significantly different between these groups, so that a higher level was observed among the elderly patients (57.09±35.39 mg/L) than the non-elderly ones (31.62±34.22 mg/L). Similarly, higher levels of BUN and LDH were seen in the elderly patients compared to the non-elderly patients (Table 2).

According to the chest CT examinations, ground glass opacities were observed in 33 (34.7%) inpatients and 7 (13.2%) outpatients, and the difference was statistically significant (P= 0.0008). Additionally, consolidation in conjunction with ground glass opacities were detected in 14 (17.7%) inpatients and 2 (3.8%) outpatients, and the difference was statistically significant (P= 0.012). In the inpatient group, 5 (5.2%) death cases were seen, while no death case was detected in the outpatients (Table 1, Figure 1).

• Download figure
• Open in new tab

Figure 1.

Representative CT Images of patients with COVID-19. A: Female, 27 years old (Outpatient) with fever and dyspnea. Axial CT image showed normal lung markings; B: Female, 35 years old (inpatient with alive outcome) with fever and dyspnea. Axial CT image showed small bilateral areas of groundglass opacities; C: Female, 60 years old (inpatient with death outcome) with cough and dyspnea, Axial CT image shows larger ground-glass opacities in the bilateral.

Discussion

In the face of the great threat posed by COVID-19 to human health, laboratory assessment and early prognosis of the patient’s condition should be given more attention. Currently, the rapid spread of COVID-19 in Bushehr, a province in southern Iran, has led to the dramatic increase in the number of hospitalized patients as well as increased mortality in the recent weeks. In this descriptive study, we evaluated 148 patients confirmed with COVID-19. Patients were divided into the outpatient and inpatient groups, and their clinical symptoms, laboratory parameters, and chest CT features were evaluated.

Since SARS-CoV-2 is a novel pathogen, the pre-existing immunity is not present in the human community, which makes all humans susceptible to the infection. In high-risk groups such as elderly people and individuals with co-existing comorbidity, outcome of infection with SARS-CoV-2 will be more serious [9]. Our results showed that among underlying medical comorbidities, type 2 diabetes, cardiovascular diseases, and hypertension were the most common in all patients with COVID-19. In addition, frequency of comorbidities was higher in the inpatients compared to the outpatients. These results are in consistent with the findings of another study conducted by Nikpouraghdam et al. in Iran [10]. They found that diabetes, hypertension, and cardiovascular diseases are amongst the most common comorbidities in COVID-19 patients. In another investigation performed by Norooznezhad et al, on 431 patients with a definite diagnosis for COVID-19 infection, underlying medical comorbidities such as cardiovascular diseases and diabetes were the most frequently identified comorbidities [11]. Shahriarirad et al. carried out a study on 113 hospitalized confirmed cases of COVID-19 admitted to hospitals in Shiraz [12]. Similar to our findings, hypertension, diabetes, and cardiovascular diseases were the most prevalent underlying comorbidities among hospitalized patients with COVID-19.

Laboratory parameters are pivotal in helping us to identify COVID-19 cases, and can use in understanding of the disease course, prognosis, and the decision-making process. As a prominent result, we observed a significant decrease in lymphocyte counts among the inpatients compared to the outpatients, and the decrease was more remarkable in elderly patients. In parallel with our findings, several recent studies have been suggested that lymphopenia is a strong indicator of infection with COVID-19 [13-16]. According to the results of a recent meta-analysis, COVID-19 patients presenting lymphopenia have an approximately 5-fold increased risk to develop severe form of the disease [17]. Several potential mechanisms leading to the lymphocyte depletion have been proposed such as direct infection and death of lymphocytes by the virus, destroying lymphatic organs, and lymphocytes inhibition by metabolic molecules produced by metabolic disorders [18].

Levels of ESR, CRP, LDH, and AST among inpatients were higher than the outpatients in our study, and the results are in accordance with the previous studies. It has been documented that elevated LDH levels are associated with worse outcomes in COVID-19 patients [19]. One of the striking findings of the present study is that there was no significant difference in the levels of creatinine and BUN between the inpatients and outpatients, while the difference was observed between elderly and non-elderly patients. This finding indicates that COVID-19 infection is associated with more severe renal failure and abnormalities in elderly patients than non-elderly ones.

Our findings showed that the prevalence of GGO and pulmonary consolidations were significantly higher among inpatients compared to outpatients. This is in line with the results of the recent meta-analysis conducted by Sun et al. They reported that GGO, consolidation, and GGO plus consolidation were the most common findings reported in 94.5% of the studies [20]. There are several limitations to our study that should be considered. First, due to the study design, some important laboratory parameters and biomarkers were not measured in our patients, such as D-dimer, B-type natriuretic peptide (BNP), N-terminal pro b-type natriuretic peptide (NT-proBNP), and Procalcitonin. Second, because of the small sample size in the study, our analyses are low in power. Third, number of patients under the age of 18 were limited, therefore, we could not perform any analysis on pediatric patients with COVID-19.

Conclusions

In summary, this study reported the clinical, laboratory, and imaging characteristics of 148 patients confirmed with COVID-19 infection in Bushehr, a southern province of Iran. The mean age of patients in the inpatient group was significantly higher than the outpatients. Also, inpatients had underlying diseases more frequently than the outpatients. The most common underlying diseases in the inpatient group were type 2 diabetes, cardiovascular diseases, hypertension and chronic lung diseases. Fever and cough were the most common symptom observed among inpatients. Ground glass opacities were observed in 34.7% of inpatients and 13.2% of outpatients. Furthermore, consolidation plus ground glass opacities were detected in 17.7% of inpatients and 3.8% of outpatients. In patients with typical manifestations and imaging changes, lymphopenia can be used as a potential indicator for diagnosis of COVID-19. Moreover, analysis of BUN and creatinine levels in serum of elderly patients showed that COVID-19 is associated with impaired renal function and related abnormalities.